HTG Molecular Diagnostics Raises $16.2M in Series D Round

The funds will be used to support increased adoption of the firm's multiplex gene expression testing platform for translational medicine, pharmaceutical clinical development, and pathology laboratory diagnostics.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories